Literature DB >> 15883714

Molecular subtyping of clinical isolates of Candida albicans and identification of Candida dubliniensis Malaysia.

S T Tay1, H C Chai, S L Na, K P Ng.   

Abstract

The genotypes of 221 recent isolates of Candida albicans from various clinical specimens of 213 patients admitted to the University Malaya Medical Centre, Malaysia was determined based on the amplification of a transposable intron region in the 25 S rRNA gene. The analyses of 178 C. albicans isolated from nonsterile clinical specimens showed that they could be classified into three genotypes: genotype A (138 isolates), genotype B (38 isolates) and genotype C (2 isolates). The genotyping of 43 clinical isolates from sterile specimens showed that they belonged to genotype A (29 isolates), genotype B (10 isolates), genotype C (2 isolates) and genotype D (2 isolates). The overall distribution of C. albicans genotypes in sterile and nonsterile specimens appeared similar, with genotype A being the most predominant type. This study reported the identification of C. dubliniensis (genotype D) in 2 HIV-negative patients with systemic candidiasis, which were missed by the routine mycological procedure. The study demonstrated the genetic diversity of clinical isolates of C. albicans in Malaysia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883714     DOI: 10.1007/s11046-004-6269-4

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  27 in total

1.  Multilocus genotyping indicates that the ability to invade the bloodstream is widespread among Candida albicans isolates.

Authors:  L N Luu; L E Cowen; C Sirjusingh; L M Kohn; J B Anderson
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Prospective study of Candida species in patients at a comprehensive cancer center.

Authors:  A Safdar; V Chaturvedi; E W Cross; S Park; E M Bernard; D Armstrong; D S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  Hospital-acquired candidemia. The attributable mortality and excess length of stay.

Authors:  S B Wey; M Mori; M A Pfaller; R F Woolson; R P Wenzel
Journal:  Arch Intern Med       Date:  1988-12

4.  PCR fingerprinting of Candida albicans associated with chronic hyperplastic candidosis and other oral conditions.

Authors:  K L Bartie; D W Williams; M J Wilson; A J Potts; M A Lewis
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron.

Authors:  M Tamura; K Watanabe; Y Mikami; K Yazawa; K Nishimura
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3.

Authors:  F Marco; S R Lockhart; M A Pfaller; C Pujol; M S Rangel-Frausto; T Wiblin; H M Blumberg; J E Edwards; W Jarvis; L Saiman; J E Patterson; M G Rinaldi; R P Wenzel; D R Soll
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

7.  Chromosomal rearrangement in Candida stellatoidea results in a positive effect on phenotype.

Authors:  B L Wickes; J E Golin; K J Kwon-Chung
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

8.  Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.

Authors:  M J McCullough; K V Clemons; D A Stevens
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

Review 9.  Non-albicans Candida infections in patients with hematologic malignancies.

Authors:  Mahomed-Yunus S Moosa; Jack D Sobel
Journal:  Semin Respir Infect       Date:  2002-06

10.  International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.

Authors:  M A Pfaller; R N Jones; G V Doern; H S Sader; R J Hollis; S A Messer
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more
  5 in total

Review 1.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

2.  Molecular analysis of Candida albicans isolates from clinical specimens.

Authors:  Melahat Gurbuz; Ilknur Kaleli
Journal:  Mycopathologia       Date:  2009-12-10       Impact factor: 2.574

3.  Issues in identifying germ tube positive yeasts by conventional methods.

Authors:  Atta Yazdanpanah; Tzar Mohd Nizam Khaithir
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

4.  Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.

Authors:  Ziauddin Khan; Suhail Ahmad; Leena Joseph; Rachel Chandy
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

5.  Growth inhibition of Candida species by Wickerhamomyces anomalus mycocin and a lactone compound of Aureobasidium pullulans.

Authors:  Sun-Tee Tay; Su-Lin Lim; Hui-Wee Tan
Journal:  BMC Complement Altern Med       Date:  2014-11-08       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.